ECO Animal Health Group plc
LSE: EAH.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David Charles Hallas
- Employees
- 227
- Headquarters
- New Malden, United Kingdom
- IPO year
- 1995
- Market cap
- £65.7M
- Website
- https://www.ecoanimalhealthgroupplc.com
Loading EAH…
Loading profile data…Frequently asked questions about EAH
What does ECO Animal Health Group plc (EAH.L) do?
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomi...
Where does EAH.L trade?
ECO Animal Health Group plc (EAH.L) trades on the London Stock Exchange.
What sector is EAH.L in?
ECO Animal Health Group plc (EAH.L) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ECO Animal Health Group plc?
David Charles Hallas is the chief executive officer of ECO Animal Health Group plc (EAH.L).
Where is ECO Animal Health Group plc headquartered?
ECO Animal Health Group plc is headquartered in United Kingdom.
Does EAH.L pay a dividend?
ECO Animal Health Group plc (EAH.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EAH.L go public?
ECO Animal Health Group plc (EAH.L) completed its initial public offering in 1995.